Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3568698

COCC1CCN(c2ccc(NC=C3C(=O)NC(=O)c4ccc(I)cc43)cc2)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PDK2 Q15119 1/20 0.32
CDK14 O94921 2/20 0.32
CCNY Q8ND76 2/20 0.32
L3MBTL1 Q9Y468 3/20 0.32
MGLL Q99685 1/20 0.31
GPR119 Q8TDV5 1/20 0.31
PDE2A O00408 1/20 0.31
LRRK2 Q5S007 1/20 0.31
APP P05067 1/20 0.31
MAPT P10636 1/20 0.31
FFAR4 Q5NUL3 2/20 0.31
RORC P51449 1/20 0.31
IDH1 O75874 1/20 0.31
PRKACA P17612 1/20 0.30
PRKACG P22612 1/20 0.30
PRKACB P22694 1/20 0.30
SLC2A1 P11166 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3568696 1.00 KDM4E (0.33) KDM4ESMN1; SMN2HSD17B10PDK2CDK14
SCHEMBL3570246 0.93 MAPT (0.35) L3MBTL1APPMAPTRORCIDH1
SCHEMBL3570243 0.93 MAPT (0.35) L3MBTL1APPMAPTRORCIDH1
Trifluoroacetic Acid SCHEMBL3570807 0.90 SYK (0.35) KDM4EHSD17B10PDK2CDK14CCNY
Trifluoroacetic Acid SCHEMBL3570797 0.90 SYK (0.35) KDM4EHSD17B10PDK2CDK14CCNY
SCHEMBL3570800 0.89 NTRK1 (0.32) PDK2GPR119LRRK2
SCHEMBL3570805 0.89 NTRK1 (0.32) PDK2GPR119LRRK2
Trifluoroacetic Acid SCHEMBL3566373 0.87 PDK2 (0.40) KDM4EHSD17B10PDK2CDK14CCNY
Trifluoroacetic Acid SCHEMBL3566369 0.87 PDK2 (0.40) KDM4EHSD17B10PDK2CDK14CCNY
Trifluoroacetic Acid SCHEMBL4694994 0.86 CDK14 (0.38) KDM4ECDK14CCNYL3MBTL1GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7713994-B2 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereof WYETH LLC (US) 2010-05-11 US disclosed
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof WYETH (US) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof SULT1E1, RECQL, HAX1 KDM4E 2158/4885SMN1; SMN2 3642/4885HSD17B10 1969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.